1
|
Aref HAT, Witry M, Olufemi-Yusuf D, Guirguis LM. Ensuring quality qualitative research reporting in community pharmacy: a systematic literature review. INTERNATIONAL JOURNAL OF PHARMACY PRACTICE 2021; 29:416-427. [PMID: 34390342 DOI: 10.1093/ijpp/riab027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2020] [Accepted: 04/30/2021] [Indexed: 11/12/2022]
Abstract
OBJECTIVES To evaluate the reporting quality for a sample of community pharmacy qualitative research articles based on the Standards for Reporting Qualitative Research (SRQR) guidelines, data interpretation and use of theory. METHODS A systematic literature search was conducted using Ovid MEDLINE to identify qualitative research related to community pharmacy. Data were extracted and evaluated based on the SRQR standards, data interpretation level and use of theory. Adherence to standards was analysed using descriptive statistics. KEY FINDINGS Eighty-one studies were retrieved through the database search (n = 81). Then, 31 studies met the inclusion criteria after screening abstracts and full texts. Twelve out of 21 SRQR were present in more than 80% of the studies. However, essential standards, such as research approach, reflexivity and trustworthiness techniques, were absent or partially present in 30 (97%) studies, 30 (97%) studies and 21 (68%) studies, respectively. Data interpretation level was descriptive in 27 (87%) studies and interpretive or partially interpretive in 4 (13%) studies. Theory was absent in 19 (60%) and implied, partially integrated or retrospectively applied in 12 (40%) of the studies. CONCLUSION Trustworthiness and quality of qualitative inferences within community pharmacy research could be enhanced with increasing awareness about reporting; the approach and paradigm, reflexivity, trustworthiness techniques, data interpretation level and theoretical use.
Collapse
Affiliation(s)
- Heba A T Aref
- Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada
| | - Matthew Witry
- Department of Pharmacy Practice and Science, Division of Health Services Research, College of Pharmacy, The University of Iowa, Iowa City, IA, USA
| | - Damilola Olufemi-Yusuf
- Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada
| | - Lisa M Guirguis
- Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada
| |
Collapse
|
2
|
Checking Inhaler Technique in the Community Pharmacy: Predictors of Critical Errors. PHARMACY 2020; 8:pharmacy8010006. [PMID: 31935995 DOI: 10.3390/pharmacy8010006] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2019] [Revised: 12/20/2019] [Accepted: 01/03/2020] [Indexed: 12/16/2022] Open
Abstract
Inhaled medications are critical in the pharmaceutical management of respiratory conditions, however, the majority of patients demonstrate at least one critical error when using an inhaler. Since community pharmacists can be instrumental in addressing this care gap, we aimed to determine the rate and type of critical inhaler errors in community pharmacy settings, elucidate the factors contributing to inhaler technique errors, and identify instances when community pharmacists check proper inhaler use. Fourth year pharmacy students on community practice placement (n = 53) identified 200 patients where at least one error was observed in 78% of participants when demonstrating inhaler technique. Prevalent errors of the users were associated with metered dose inhaler (MDI) (55.6%), Ellipta® (88.3%), and Discus® (86.7%) devices. Overall, the mean number of errors was 1.09. Possession of more than one inhaler, use of rescue inhaler, and poor control of asthma were found to be significant predictors of having at least one critical error. In all participating pharmacies, inhaler technique is mainly checked on patient request (93.0%) and for all new inhalers (79.0%).
Collapse
|
3
|
Ruud KW, Rønningen SW, Faksvåg PK, Ariansen H, Hovland R. Evaluation of a structured pharmacist-led inhalation technique assessment service for patients with asthma and COPD in Norwegian pharmacies. PATIENT EDUCATION AND COUNSELING 2018; 101:1828-1837. [PMID: 29805072 DOI: 10.1016/j.pec.2018.05.018] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/17/2017] [Revised: 05/04/2018] [Accepted: 05/19/2018] [Indexed: 06/08/2023]
Abstract
OBJECTIVE To investigate whether the inhalation technique improved among patients with asthma and chronic obstructive pulmonary disease after an Inhalation Technique Assessment Service (ITAS), and to assess the patients' and pharmacists' perceptions of ITAS. METHODS This uncontrolled, pre-post study included 405 patients recruited from 42 Norwegian pharmacies. Inhalation technique was assessed by trained pharmacists before ITAS (baseline), directly after (follow-up 1) and three months after ITAS (follow-up 2), and analyzed statistically using SPSS. Perceptions of ITAS were assessed using a questionnaire. RESULTS 488 ITAS were performed. At baseline, 8% of the inhalation technique demonstrations were rated as optimal and 31% as acceptable. Following ITAS, this increased to 72% (optimal) and 86% (acceptable). At follow-up 2 inhalation technique remained significantly higher than baseline (optimal: 52%, acceptable: 75%). The median rate of wrong steps decreased from 25% (baseline) to 0% (follow-ups). The usefulness of ITAS was rated 4 on a 5-point Likert scale. CONCLUSION Inhalation technique improved significantly after ITAS for both new and experienced users and all assessed devices. The technique remained significantly improved at follow-up 2. ITAS was well accepted by pharmacists and patients. PRACTICE IMPLICATIONS ITAS can contribute to significant improvements in inhalation technique among patients using inhaler devices.
Collapse
Affiliation(s)
- Karine Wabø Ruud
- APOKUS, National Centre for Development of Pharmacy Practice, Oslo, Norway.
| | | | | | | | - Ragnar Hovland
- APOKUS, National Centre for Development of Pharmacy Practice, Oslo, Norway
| |
Collapse
|
4
|
Volmer D, Sokirskaja A, Laaksonen R, Vainio K, Sandler N, Halvorsen KH, Kjome RLS, Gizurarson S, Muceniece R, Maurina B, Dauksiene J, Ruuben L, Björnsdottir I, Ratassepp T, Heinämäki J. Perception of the Professional Knowledge of and Education on the Medical Technology Products among the Pharmacists in the Baltic and Nordic Countries-A Cross-Sectional Exploratory Study. PHARMACY 2016; 4:pharmacy4040029. [PMID: 28970402 PMCID: PMC5419374 DOI: 10.3390/pharmacy4040029] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2016] [Revised: 09/23/2016] [Accepted: 10/11/2016] [Indexed: 01/01/2023] Open
Abstract
With increased development of medical technology (MT), new challenges emerge related to education and training of pharmacists and other healthcare specialists. Currently, only a few universities in the EU promote MT education and research. Objectives: The aim of this study was to evaluate the current status, views on, and need for the education on MT for the pharmacy students and practicing pharmacists in the Baltic and Nordic countries. Methods: The representatives of higher education institutions and community/hospital pharmacists from six Baltic and Nordic countries participated in a qualitative cross-sectional exploratory internet-based study from May to October 2014. Results: Approximately two-third of the respondents considered professional knowledge about MT products important for pharmacists, but half of them had never participated in any MT courses. More practicing pharmacists than representatives of academia underlined the need for increased MT education for pharmacy students in the future. Conclusions: The pharmacists in the Baltic and Nordic countries consider the professional knowledge about MT as pertinent in their education and work. The limited number and status of MT courses available today, however, is a major concern among both pharmacy students and practicing pharmacists in these countries. In the future, increasing education combining theory and practice about MT products would be one possible solution to overcome this challenge.
Collapse
Affiliation(s)
- Daisy Volmer
- Institute of Pharmacy, Faculty of Medicine, University of Tartu, 1 Nooruse Str., 50411 Tartu, Estonia.
| | - Aleksandra Sokirskaja
- Institute of Pharmacy, Faculty of Medicine, University of Tartu, 1 Nooruse Str., 50411 Tartu, Estonia.
| | - Raisa Laaksonen
- Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Viikinkaari 9 (P.O. Box 56), 00014 Helsinki, Finland.
| | - Kirsti Vainio
- School of Pharmacy, University of Eastern Finland, P.O. Box 1627, 70211 Kuopio, Finland.
| | - Niklas Sandler
- Pharmaceutical Sciences, Åbo Akademi University, BioCity, Artillerigatan 6A FI, 20520 Turku, Finland.
| | - Kjell H Halvorsen
- Department of Pharmacy, Faculty of Health Science, UiT The Arctic University of Norway, 9037 Tromsø, Norway.
| | | | | | - Ruta Muceniece
- Department of Pharmacy, Faculty of Medicine, University of Latvia, LV-1050 Riga, Latvia.
| | - Baiba Maurina
- Faculty of Pharmacy, Riga Stradins University, LV-1007 Riga, Latvia.
| | - Jurgita Dauksiene
- Department of Drug Technology and Social Pharmacy, Faculty of Pharmacy, Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania.
| | - Lilian Ruuben
- Tallinn Health Care College, 13418 Tallinn, Estonia.
| | - Ingunn Björnsdottir
- School of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, 0316 Oslo, Norway.
| | - Tagne Ratassepp
- Medical Device Department, Estonian Health Board, 50303 Tartu, Estonia.
| | - Jyrki Heinämäki
- Institute of Pharmacy, Faculty of Medicine, University of Tartu, 1 Nooruse Str., 50411 Tartu, Estonia.
| |
Collapse
|